BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/30/2015 3:22:00 PM | Browse: 655 | Download: 1405
Publication Name World Journal of Pharmacology
Manuscript ID 15571
Country/Territory United States
Received
2014-11-29 13:38
Peer-Review Started
2014-11-29 15:46
To Make the First Decision
2015-01-08 14:00
Return for Revision
2015-01-14 14:16
Revised
2015-01-28 00:45
Second Decision
2015-03-16 17:49
Accepted by Journal Editor-in-Chief
2015-03-16 21:08
Accepted by Company Editor-in-Chief
2015-04-02 16:21
Articles in Press
2015-04-02 16:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-06-01 16:00
Publish the Manuscript Online
2015-06-19 15:32
ISSN 2220-3192 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Tropical Medicine
Manuscript Type Minireviews
Article Title Therapeutic options and vaccine development in the treatment of leishmaniasis
Manuscript Source Invited Manuscript
All Author List Jill E Weatherhead and Laila Woc-Colburn
Funding Agency and Grant Number
Corresponding Author Laila Woc-Colburn, MD, DTM&H, FACP, Department of Medicine, Baylor College of Medicine, Room BCM164A, One Baylor Plaza, BCM113, Houston, TX 77030, United States. woccolbu@bcm.edu
Key Words Leishmania; Visceral; Cutaneous; Mucocu­taneous; Amphoterecin; Vaccine
Core Tip Leishmaniasis is an old disease, hard to diagnose and even harder to treat. Limited treatment is available. Early treatment of leishmaniasis is critical to achieve cure, prevent psychological and social distress, and prevent transmission of disease. Untreated Leishmaniasis - cutaneous leishmaniasis, mucocutaneous leishmaniasis and visceral leishmaniasis - results in disfiguring scars and high rates of morbidity and mortality in highly endemic regions of the world. Cure rates with available therapeutics are limited due to cost, therapeutic toxicity and the growing rate of resistance. There is an emergent need for development of new therapeutic options with improved tolerability, improved healing process minimizing scarring, and improved efficacy amongst all Leishmania spp.
Publish Date 2015-06-19 15:32
Citation Weatherhead JE, Woc-Colburn L. Therapeutic options and vaccine development in the treatment of leishmaniasis. World J Pharmacol 2015; 4(2): 210-218
URL http://www.wjgnet.com/2220-3192/full/v4/i2/210.htm
DOI http://dx.doi.org/10.5497/wjp.v4.i2.210
Full Article (PDF) WJP-4-210.pdf
Full Article (Word) WJP-4-210.doc
Manuscript File 15571-Review.docx
Answering Reviewers 15571-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 15571-Conflict-of-interest statement.pdf
Copyright License Agreement 15571-Copyright assignment.pdf
Peer-review Report 15571-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 15571-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 15571-Scientific misconduct check.pdf
Scientific Editor Work List 15571-Scientific editor work list.pdf